Sildenafil For Suspension
Product Images NDC 69543-419

18 FDA label images from Virtus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 69543-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Virtus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Stru (Structure)

Stru (Structure)
Chemical structure of sildenafil, the active ingredient in the product sildenafil oral suspension 10 mg/mL by Virtus Pharmaceuticals. The diagram shows the molecule's arrangement including rings, bonds, and functional groups characteristic of sildenafil.*
FDA Label Image

Fig7 (Fig7)

Fig7 (Fig7)
A chart showing the fold change and 90% confidence interval of various drugs interacting with sildenafil, measuring AUC and Cmax relative to sildenafil alone. It includes a recommendation column indicating dose adjustments or coadministration advice for drugs like Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir.*
FDA Label Image

Fig8 (Fig8)

Fig8 (Fig8)
A forest plot chart depicting drug interactions with sildenafil, showing fold change and 90% confidence intervals for various pharmacokinetic parameters such as AUC and Cmax. The chart lists interacting drugs on the left, with corresponding dose adjustment recommendations on the right. The x-axis represents fold change relative to the interacting drug alone, with a vertical reference line at 1. Notes include specific sildenafil doses for doxazosin and study-based explanations for certain recommendations.*
FDA Label Image

Fig9 (Fig9)

Fig9 (Fig9)
A line graph depicting change from baseline in a measured parameter (in meters) over 12 weeks of study. The x-axis shows weeks 4, 8, and 12, while the y-axis measures change from baseline ranging from -20 to 80 meters. Data points represent four groups: placebo, sildenafil 20mg TID, sildenafil 40mg TID, and sildenafil 80mg TID, each with error bars indicating variability.*
FDA Label Image

Fig10 (Fig10)

Fig10 (Fig10)
A forest plot chart showing placebo-corrected changes in 6-minute walk distance in meters for sildenafil 20 mg TID across subgroups including baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary artery pressure (PAP), and pulmonary vascular resistance index (PVRI). Each subgroup compares sildenafil versus placebo with confidence intervals.*
FDA Label Image

Fig11 (Fig11)

Fig11 (Fig11)
A survival curve chart showing the percentage of subjects without a clinically worsening event over time, comparing sildenafil and placebo groups. The x-axis represents days from randomization up to 112 days, while the y-axis shows the percentage without worsening events from 0% to 100%. The sildenafil group maintains a higher percentage over time compared to placebo.*
FDA Label Image

Sildinafil-spl-image3 (Sildinafil Spl Image3)

Sildinafil-spl-image3 (Sildinafil Spl Image3)
A table presenting package configuration and strength information for sildenafil oral suspension. It specifies the product as powder for oral suspension in a 125 mL amber glass bottle, with a strength of 10 mg/mL when reconstituted and NDC 69543-419-72.*
FDA Label Image

Sildenafil-spl-figureb (Sildenafil Spl Figureb)

Sildenafil-spl-figureb (Sildenafil Spl Figureb)
An instructional illustration showing a hand holding a bottle, demonstrating shaking motions with curved arrows around the cap and body of the bottle, accompanied by a stopwatch displaying elapsed time. This indicates proper mixing or shaking of an oral suspension before use.*
FDA Label Image

Sildenafil-spl-figurec (Sildenafil Spl Figurec)

Sildenafil-spl-figurec (Sildenafil Spl Figurec)
An instructional illustration labeled Figure C showing a hand gripping and twisting the cap of a bottle, indicating how to open it by pushing down and turning the cap. The bottle is partially filled with liquid, consistent with a pharmaceutical suspension container.*
FDA Label Image

Sildenafil-spl-figured (Sildenafil Spl Figured)

Sildenafil-spl-figured (Sildenafil Spl Figured)
An instructional diagram illustrating the use of an oral suspension bottle with a dosing syringe. The image shows a hand pressing down on the syringe plunger and inserting the syringe into the suspension bottle to draw liquid medication. The diagram is a step in measuring the correct dose from the bottle.*
FDA Label Image

Fige (Fige)

Fige (Fige)
An illustration showing a syringe inserted into the top of a bottle, with an upward arrow indicating the syringe plunger should be pulled up. The image likely demonstrates how to draw medication from the bottle.*
FDA Label Image

Figf (Figf)

Figf (Figf)
An instructional illustration showing the administration of oral suspension medication with a syringe into a person's mouth. The syringe is positioned at the lips for precise dosing.*
FDA Label Image

Sild-spl-figg (Sild Spl Figg)

Sild-spl-figg (Sild Spl Figg)
An instructional illustration showing an adult taking an oral suspension medication with a syringe. The hand holds the syringe near the lips, and the arrow indicates the direction of administration into the mouth.*
FDA Label Image

Sildenafil-spl-figureh (Sildenafil Spl Figureh)

Sildenafil-spl-figureh (Sildenafil Spl Figureh)
An instructional illustration labeled 'Figure H' showing a hand gripping and twisting the cap of an oral suspension bottle to open or close it. The image emphasizes the cap rotation with arrows indicating turning direction.*
FDA Label Image

Sildenafil-spl-figurei (Sildenafil Spl Figurei)

Sildenafil-spl-figurei (Sildenafil Spl Figurei)
An instructional diagram showing a faucet dispensing water into two oral dosing syringes, one labeled 0.5 mL and the other 2 mL, likely illustrating the proper measurement or preparation of an oral suspension dose.*
FDA Label Image
FDA Label Image

Sildenafil-spl-carton (Sildenafil Spl Carton)

Sildenafil-spl-carton (Sildenafil Spl Carton)
Label for sildenafil for oral suspension 10 mg/mL by Virtus Pharmaceuticals, LLC. The label includes directions for reconstitution to 112 mL total volume, storage instructions, and dosage information. The oral suspension is grape flavored and for oral use only.*
FDA Label Image

Sildenafil-spl-label (Sildenafil Spl Label)

Sildenafil-spl-label (Sildenafil Spl Label)
Label for sildenafil oral suspension, 10 mg/mL strength, distributed by Virtus Pharmaceuticals, LLC. The label states the product is for oral use only, with a volume of 112 mL after reconstitution. Storage instructions before and after reconstitution are provided, along with a notice to shake well before use. The suspension is grape flavored and the label includes the NDC 69543-419-72 barcode and company logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.